Accéder au contenu
Merck

Urocortin 3 administration impairs fear motivated learning in mice is mediated by transmitters.

Behavioural brain research (2014-05-13)
G Telegdy, L Foris, M Jászberényi
RÉSUMÉ

Urocortin 3 (Ucn 3) was found to impair passive avoidance learning in male and female mice. The possible involvement of transmitters in the action, the animals were pretreated with the following receptor antagonists in doses which alone could not influence the measurement. Haloperidol (a D2, dopamine receptor antagonist), phenoxybenzamine (a nonselective α1-adrenergic receptor antagonist), atropine (a nonselective muscarinic acetylcholine receptor antagonist), bicuculline (a γ-aminobutyric acid subunit A receptor antagonist), nitro-L-arginine (a nitric oxide synthase inhibitor), antalarmin (a CRF1 receptor antagonist) and astressin 2B (a CRF2 receptor antagonist). Haloperidol, phenoxybenzamine, bicuculline, atropine, nitro-L-arginine and astressin 2B prevented the action of Ucn 3, in both sexes, whereas antalarmin exerted no action in either male or female animals.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Haloperidol, powder
Sigma-Aldrich
(+)-Bicuculline, ≥97.0% (TLC)
USP
Haloperidol, United States Pharmacopeia (USP) Reference Standard
Atropine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Phenoxybenzamine hydrochloride, ≥97%, powder
Supelco
Phenoxybenzamine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Phenoxybenzamine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard
Haloperidol, European Pharmacopoeia (EP) Reference Standard
Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard
Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard